This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Daisuke Takahashi, PhD
Executive Specialist at Ajinomoto Co. Inc.
Speaker

Profile

Dr. Takahashi graduated Nihon University and earned Ph.D degree in 2012 from Gifu pharmaceutical University. After joining AJINOMOTO Co., Inc., He worked as a process chemist in amino acids, nucleosides and heterocyclic chemistry fields. He published on 8 scientific papers and more than 30 of patents so far. He commenced to research regarding peptide field in 2005 and is originator of AJIPHASE® technology which combine strong point of solid-phase chemistry and liquid-phase chemistry. He earned the International Symposium on Process Chemistry award in 2011. He is currently working on oligonucleotides and peptides chemistry as a leader of R&D in AJINOMOTO.

Agenda Sessions

  • Enzymatic Oligonucleotide Manufacturing Combination with Solution Based Approach AJIPHASE® for Large Scale

    13:25